Sonar “is a celebration and distillation of all of those player voices” talking about a game, Sprung Studio CEO James Chaytor ...

It has been five years since Lexicon Pharma's type 1 diabetes therapy, Zynquista, was rejected by the FDA, and it may struggle to have a better outcome at its second attempt. An FDA advisory committee ...

Every investor in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are private equity firms ...

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company ...

There are a number of rare collector’s items in the sale, including a modified Moog Model 15 synthesizer purchased by John in ...

Get the detailed quarterly/annual income statement for Lexicon Pharmaceuticals, Inc. (LXRX). Find out the revenue, expenses and profit or loss over the last fiscal year.

Back when Minecraft was relatively new and was released on several new platforms, 4J Studios added a unique way to introduce players to the sandbox game. In the early days, Legacy Console Editions for ...

The Daily News Sentiment Index is a high frequency measure of economic sentiment based on lexical analysis of economics-related news articles. The index is described in Buckman, Shapiro, Sudhof, and ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally ...